Index

A1C, S5, S8, S11, S12, S20,S21 –S22, S97 –S99advantages of, S21age and, S21 –S22cardiovascular disease and, S102 –S103CGM technology effect on, S106, S112, S115 –S116confirming diagnosis with, S22correlation with BGM, S98hemoglobinopathies and,S22in children, S98 –S99, S235–S237, S241–S242in hospitalized patients, S268in older adults, S219, S220, S223in people with HIV,S28in screening children,S28limitations,S98microvascular complications and, S101 –S102other conditions affecting,S22point-of-care assays, S5, S21, S98in prediabetes, S24 –S25in pregnancy, S256,S257 –S258race/ethnicity and,S22, S98 –S99recommendations,S21setting and modifying goals for, S103 –S104
Source: Diabetes Care - Category: Endocrinology Source Type: research